Polish (WIG) Biotech Industry Analysis
UpdatedMay 29, 2024
DataAggregated Company Financials
Companies13
- 7D-1.6%
- 3M-4.9%
- 1Y-19.3%
- YTD-9.8%
Over the last 7 days, the Biotech industry has dropped 2.1%, driven by a pullback from Mabion of 6.2%. The industry has fallen 20% in the last year. As for the next few years, earnings are expected to grow by 11% per annum.
Industry Valuation and Performance
Has the Polish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 29 May 2024 | zł2.2b | zł439.7m | -zł97,717,228.00 | 71x | -22.8x | 5.1x |
| Fri, 26 Apr 2024 | zł2.3b | zł441.3m | -zł93,380,007.00 | 55.5x | -24.2x | 5.1x |
| Sun, 24 Mar 2024 | zł2.2b | zł462.1m | -zł74,341,007.00 | 58.9x | -29.1x | 4.7x |
| Tue, 20 Feb 2024 | zł2.3b | zł462.1m | -zł74,341,007.00 | 60.2x | -31.4x | 5.1x |
| Thu, 18 Jan 2024 | zł2.7b | zł499.9m | -zł66,755,911.00 | 88.6x | -40.5x | 5.4x |
| Sat, 16 Dec 2023 | zł2.8b | zł499.9m | -zł66,755,911.00 | 93.3x | -41.6x | 5.6x |
| Mon, 13 Nov 2023 | zł2.6b | zł511.7m | -zł63,340,678.00 | 46.2x | -41.5x | 5.1x |
| Wed, 11 Oct 2023 | zł2.7b | zł518.4m | -zł60,859,678.00 | 48.7x | -43.8x | 5.1x |
| Fri, 08 Sep 2023 | zł2.8b | zł521.0m | -zł47,585,668.00 | 49.7x | -59.9x | 5.5x |
| Sun, 06 Aug 2023 | zł2.8b | zł520.7m | -zł42,515,291.00 | 51.6x | -66.8x | 5.5x |
| Tue, 04 Jul 2023 | zł2.9b | zł520.7m | -zł42,515,291.00 | 53.4x | -67x | 5.5x |
| Thu, 01 Jun 2023 | zł2.9b | zł515.9m | -zł50,000,721.00 | 62.7x | -57.2x | 5.5x |
| Sat, 29 Apr 2023 | zł2.9b | zł536.5m | -zł32,904,449.00 | 68.2x | -89.3x | 5.5x |
| Mon, 27 Mar 2023 | zł2.7b | zł488.3m | -zł16,018,449.00 | 57.1x | -168.4x | 5.5x |
| Wed, 22 Feb 2023 | zł3.0b | zł488.6m | -zł16,165,349.00 | 67.4x | -184.7x | 6.1x |
| Fri, 20 Jan 2023 | zł2.9b | zł496.5m | -zł10,783,764.00 | 46.9x | -271.4x | 5.9x |
| Sun, 18 Dec 2022 | zł2.6b | zł496.5m | -zł10,783,764.00 | 44.9x | -243.4x | 5.3x |
| Tue, 15 Nov 2022 | zł2.7b | zł460.6m | -zł17,905,868.00 | 47.7x | -151.2x | 5.9x |
| Thu, 13 Oct 2022 | zł2.6b | zł444.0m | -zł13,473,868.00 | 57.4x | -190.6x | 5.8x |
| Sat, 10 Sep 2022 | zł2.8b | zł401.3m | -zł17,023,868.00 | 60.9x | -163.2x | 6.9x |
| Mon, 08 Aug 2022 | zł2.8b | zł437.0m | -zł17,043,314.00 | 36.4x | -166.9x | 6.5x |
| Wed, 06 Jul 2022 | zł2.4b | zł472.9m | zł66,686.00 | 25.2x | 35595.6x | 5x |
| Fri, 03 Jun 2022 | zł2.5b | zł468.2m | zł39.0m | 25x | 63.8x | 5.3x |
| Sun, 01 May 2022 | zł2.6b | zł369.1m | -zł37,778,677.00 | 35x | -69.4x | 7.1x |
| Tue, 29 Mar 2022 | zł2.7b | zł348.8m | -zł40,884,677.00 | 32.8x | -67.2x | 7.9x |
| Thu, 24 Feb 2022 | zł3.0b | zł348.8m | -zł40,884,677.00 | 33.4x | -73.3x | 8.6x |
| Sat, 22 Jan 2022 | zł3.4b | zł369.9m | -zł24,922,742.00 | 48.1x | -138.2x | 9.3x |
| Mon, 20 Dec 2021 | zł3.9b | zł369.9m | -zł24,922,742.00 | 49.2x | -154.9x | 10.4x |
| Wed, 17 Nov 2021 | zł3.6b | zł367.1m | zł91,715.00 | 35.1x | 38991.6x | 9.7x |
| Fri, 15 Oct 2021 | zł3.7b | zł364.5m | -zł1,455,285.00 | 34.4x | -2570.2x | 10.3x |
| Sun, 12 Sep 2021 | zł3.5b | zł364.5m | -zł1,456,285.00 | 37.7x | -2412.6x | 9.6x |
| Tue, 10 Aug 2021 | zł3.6b | zł362.9m | -zł8,912,285.00 | 40.5x | -409.2x | 10x |
Price to Earnings Ratio
-550.4x
Current Industry PE
- Investors are pessimistic on the Polish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 6.8x is higher than the industry's current PS ratio of 5.0x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 5.6% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | -1.76% | |
| Healthcare | -1.01% | |
| Biotech | -1.60% | |
| Biotech | -1.60% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CTX Captor Therapeutics Spolka Akcyjna | zł78.60 | 2.9% +zł10.2m | -51.5% | PS29.1x | |
| GX1 genXone | zł6.30 | 5.0% +zł989.0k | -35.7% | PS10.3x |